nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Prednisone—ankylosing spondylitis	0.342	0.666	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—ankylosing spondylitis	0.172	0.334	CbGbCtD
Gadobenate Dimeglumine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000667	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000664	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000659	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000658	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000658	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Prednisone—ankylosing spondylitis	0.000657	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000655	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000654	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Methotrexate—ankylosing spondylitis	0.000654	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000653	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Prednisone—ankylosing spondylitis	0.000652	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000652	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000652	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000651	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00065	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000645	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Methotrexate—ankylosing spondylitis	0.000643	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000642	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Betamethasone—ankylosing spondylitis	0.000642	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Prednisone—ankylosing spondylitis	0.000638	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000636	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000636	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000635	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Dexamethasone—ankylosing spondylitis	0.000633	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Betamethasone—ankylosing spondylitis	0.000633	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000632	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00063	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Dexamethasone—ankylosing spondylitis	0.00063	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Betamethasone—ankylosing spondylitis	0.00063	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000628	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Infection—Triamcinolone—ankylosing spondylitis	0.000628	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Methotrexate—ankylosing spondylitis	0.000627	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methylprednisolone—ankylosing spondylitis	0.000626	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—ankylosing spondylitis	0.000624	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Shock—Triamcinolone—ankylosing spondylitis	0.000622	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Shock—Methylprednisolone—ankylosing spondylitis	0.00062	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000618	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000617	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000617	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000617	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000617	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Prednisone—ankylosing spondylitis	0.000616	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000615	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000612	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Prednisone—ankylosing spondylitis	0.000612	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Prednisone—ankylosing spondylitis	0.000612	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000611	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000609	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000606	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Betamethasone—ankylosing spondylitis	0.000606	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Betamethasone—ankylosing spondylitis	0.000598	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000598	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000596	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Betamethasone—ankylosing spondylitis	0.000596	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Betamethasone—ankylosing spondylitis	0.000591	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000591	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000589	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Pain—Prednisolone—ankylosing spondylitis	0.000587	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00058	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000576	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000576	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000574	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000573	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000573	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Infection—Dexamethasone—ankylosing spondylitis	0.000569	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Infection—Betamethasone—ankylosing spondylitis	0.000569	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000568	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000567	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000566	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000566	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000566	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Prednisone—ankylosing spondylitis	0.000565	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Shock—Betamethasone—ankylosing spondylitis	0.000564	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Shock—Dexamethasone—ankylosing spondylitis	0.000564	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000563	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000562	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000562	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000559	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000559	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Prednisone—ankylosing spondylitis	0.000559	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000556	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000555	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000554	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000554	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Prednisone—ankylosing spondylitis	0.000552	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000549	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Prednisone—ankylosing spondylitis	0.000549	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000548	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisolone—ankylosing spondylitis	0.000546	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000545	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000545	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000543	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Pain—Triamcinolone—ankylosing spondylitis	0.00054	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000538	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Betamethasone—ankylosing spondylitis	0.000536	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000536	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000533	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00053	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000529	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Prednisone—ankylosing spondylitis	0.000528	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—ankylosing spondylitis	0.000527	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000522	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000522	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Prednisone—ankylosing spondylitis	0.000521	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Prednisone—ankylosing spondylitis	0.000521	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000521	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000519	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Prednisone—ankylosing spondylitis	0.000519	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000517	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000515	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000515	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000515	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Prednisone—ankylosing spondylitis	0.000515	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000514	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—ankylosing spondylitis	0.000511	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000511	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000506	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000505	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000505	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000502	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000501	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000501	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000499	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000499	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000498	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Infection—Prednisone—ankylosing spondylitis	0.000496	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000495	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000495	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—ankylosing spondylitis	0.000494	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000494	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Betamethasone—ankylosing spondylitis	0.000494	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Shock—Prednisone—ankylosing spondylitis	0.000491	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Pain—Dexamethasone—ankylosing spondylitis	0.00049	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Pain—Betamethasone—ankylosing spondylitis	0.00049	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00049	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Prednisone—ankylosing spondylitis	0.000487	0.001	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Prednisone—ankylosing spondylitis	0.000485	0.000997	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000483	0.000992	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000474	0.000975	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—ankylosing spondylitis	0.000472	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000472	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000472	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000469	0.000963	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000469	0.000963	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000465	0.000957	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000464	0.000954	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—ankylosing spondylitis	0.000461	0.000947	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000458	0.00094	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Betamethasone—ankylosing spondylitis	0.000455	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000455	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000455	0.000935	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisolone—ankylosing spondylitis	0.000454	0.000934	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000453	0.000932	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000453	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000453	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000453	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000453	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000452	0.000929	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000448	0.000921	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000447	0.000919	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—ankylosing spondylitis	0.000446	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000446	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000439	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000435	0.000894	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—ankylosing spondylitis	0.000435	0.000894	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—ankylosing spondylitis	0.000435	0.000894	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisolone—ankylosing spondylitis	0.000433	0.00089	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000433	0.000889	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000432	0.000888	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000431	0.000886	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Prednisone—ankylosing spondylitis	0.00043	0.000885	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisolone—ankylosing spondylitis	0.00043	0.000885	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—ankylosing spondylitis	0.00043	0.000884	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Prednisone—ankylosing spondylitis	0.000427	0.000877	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—ankylosing spondylitis	0.000421	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000418	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000417	0.000857	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000417	0.000857	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—ankylosing spondylitis	0.000414	0.000852	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000411	0.000845	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000411	0.000845	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Betamethasone—ankylosing spondylitis	0.000411	0.000845	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000409	0.000841	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000408	0.000839	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisolone—ankylosing spondylitis	0.000408	0.000839	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000406	0.000834	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Betamethasone—ankylosing spondylitis	0.000406	0.000834	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000405	0.000833	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000403	0.000829	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000402	0.000826	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000401	0.000824	CcSEcCtD
Gadobenate Dimeglumine—Rash—Triamcinolone—ankylosing spondylitis	0.000398	0.000819	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000398	0.000818	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methylprednisolone—ankylosing spondylitis	0.000397	0.000817	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000397	0.000816	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisone—ankylosing spondylitis	0.000397	0.000815	CcSEcCtD
Gadobenate Dimeglumine—Headache—Triamcinolone—ankylosing spondylitis	0.000396	0.000813	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methylprednisolone—ankylosing spondylitis	0.000395	0.000812	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000395	0.000811	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000395	0.000811	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000392	0.000806	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000392	0.000806	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—ankylosing spondylitis	0.00039	0.000801	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00038	0.000781	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Betamethasone—ankylosing spondylitis	0.000379	0.000779	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000379	0.000779	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Triamcinolone—ankylosing spondylitis	0.000375	0.000771	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000375	0.00077	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000374	0.00077	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000372	0.000764	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—ankylosing spondylitis	0.000371	0.000762	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000368	0.000756	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000367	0.000755	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000364	0.000749	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Betamethasone—ankylosing spondylitis	0.000364	0.000749	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dexamethasone—ankylosing spondylitis	0.000361	0.000743	CcSEcCtD
Gadobenate Dimeglumine—Rash—Betamethasone—ankylosing spondylitis	0.000361	0.000743	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000361	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000361	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00036	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—ankylosing spondylitis	0.00036	0.000739	CcSEcCtD
Gadobenate Dimeglumine—Headache—Dexamethasone—ankylosing spondylitis	0.000359	0.000738	CcSEcCtD
Gadobenate Dimeglumine—Headache—Betamethasone—ankylosing spondylitis	0.000359	0.000738	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Prednisone—ankylosing spondylitis	0.000358	0.000736	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—ankylosing spondylitis	0.000357	0.000733	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Prednisone—ankylosing spondylitis	0.000353	0.000726	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000344	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000342	0.000702	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000341	0.000701	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Betamethasone—ankylosing spondylitis	0.00034	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dexamethasone—ankylosing spondylitis	0.00034	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—ankylosing spondylitis	0.000331	0.000681	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisone—ankylosing spondylitis	0.00033	0.000678	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00033	0.000678	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00033	0.000678	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Prednisone—ankylosing spondylitis	0.000317	0.000652	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisone—ankylosing spondylitis	0.000315	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisone—ankylosing spondylitis	0.000314	0.000646	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisone—ankylosing spondylitis	0.000313	0.000643	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000307	0.000632	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—ankylosing spondylitis	0.000299	0.000615	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisone—ankylosing spondylitis	0.000297	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—ankylosing spondylitis	0.000295	0.000607	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000285	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—ankylosing spondylitis	0.000276	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—ankylosing spondylitis	0.000265	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—ankylosing spondylitis	0.000263	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000263	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—ankylosing spondylitis	0.000261	0.000537	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—ankylosing spondylitis	0.000248	0.000509	CcSEcCtD
